SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041524
Filing Date
2019-11-07
Accepted
2019-11-07 12:53:22
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20190930.htm 10-Q 1881526
2 EX-10.2 apvo-ex102_63.htm EX-10.2 16847
3 EX-31.1 apvo-ex311_62.htm EX-31.1 19304
4 EX-31.2 apvo-ex312_61.htm EX-31.2 19478
5 EX-32.1 apvo-ex321_59.htm EX-32.1 10297
6 EX-32.2 apvo-ex322_60.htm EX-32.2 10404
  Complete submission text file 0001564590-19-041524.txt   5588635

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT apvo-20190930.xml EX-101.INS 874850
8 XBRL TAXONOMY EXTENSION SCHEMA apvo-20190930.xsd EX-101.SCH 52430
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20190930_cal.xml EX-101.CAL 47696
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20190930_def.xml EX-101.DEF 153221
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20190930_lab.xml EX-101.LAB 396200
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20190930_pre.xml EX-101.PRE 285179
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 191199340
SIC: 2834 Pharmaceutical Preparations